AAAAAA

   
Results: 1-13 |
Results: 13
INCREASED USE OF IMMUNOHISTOCHEMISTRY FOR ESTROGEN-RECEPTOR MEASUREMENT IN MAMMARY-CARCINOMA - THE NEED FOR QUALITY ASSURANCE
Authors: BARNES DM MILLIS RR BEEX LVAM THORPE SM LEAKE RE
Citation: Dm. Barnes et al., INCREASED USE OF IMMUNOHISTOCHEMISTRY FOR ESTROGEN-RECEPTOR MEASUREMENT IN MAMMARY-CARCINOMA - THE NEED FOR QUALITY ASSURANCE, European journal of cancer, 34(11), 1998, pp. 1677-1682
THE HEART OF THE MATTER
Authors: LEAKE RE
Citation: Re. Leake, THE HEART OF THE MATTER, ABA journal, 83, 1997, pp. 14-14
IMMUNOASSAYS (ELISA) OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (UPA) - REPORT OF AN EORTC BIOMED-1 WORKSHOP/
Authors: BENRAAD TJ GEURTSMOESPOT J GRONDAHLHANSEN J SCHMITT M HEUVEL JJTM DEWITTE JH FOEKENS JA LEAKE RE BRUNNER N SWEEP CGJ
Citation: Tj. Benraad et al., IMMUNOASSAYS (ELISA) OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (UPA) - REPORT OF AN EORTC BIOMED-1 WORKSHOP/, European journal of cancer, 32A(8), 1996, pp. 1371-1381
STEROID-GROWTH FACTOR INTERACTION IN HUMAN PROSTATE-CANCER .2. EFFECTS OF TRANSFORMING GROWTH-FACTORS ON ANDROGEN METABOLISM OF PROSTATE-CANCER CELLS
Authors: CARRUBA G GRANATA OM FARRUGGIO R CANNELLA S LOBUE A LEAKE RE PAVONEMACALUSO M CASTAGNETTA LAM
Citation: G. Carruba et al., STEROID-GROWTH FACTOR INTERACTION IN HUMAN PROSTATE-CANCER .2. EFFECTS OF TRANSFORMING GROWTH-FACTORS ON ANDROGEN METABOLISM OF PROSTATE-CANCER CELLS, Steroids, 61(1), 1996, pp. 41-46
DETECTION AND DISTRIBUTION OF HEAT-SHOCK-PROTEIN-27 AND HEAT-SHOCK-PROTEIN-90 IN HUMAN BENIGN AND MALIGNANT PROSTATIC TISSUE
Authors: THOMAS SA BROWN IL HOLLINS GW HOCKEN A KIRK D KING RJB LEAKE RE
Citation: Sa. Thomas et al., DETECTION AND DISTRIBUTION OF HEAT-SHOCK-PROTEIN-27 AND HEAT-SHOCK-PROTEIN-90 IN HUMAN BENIGN AND MALIGNANT PROSTATIC TISSUE, British Journal of Urology, 77(3), 1996, pp. 367-372
CONCLUSIONS AND RECOMMENDATIONS FROM THE HELENE-HARRIS-MEMORIAL-TRUST5TH BIENNIAL INTERNATIONAL FORUM ON OVARIAN-CANCER, MAY 4-7, 1995, GLASGOW, UK
Authors: SHARP F BLACKETT AD LEAKE RE BEREK JS
Citation: F. Sharp et al., CONCLUSIONS AND RECOMMENDATIONS FROM THE HELENE-HARRIS-MEMORIAL-TRUST5TH BIENNIAL INTERNATIONAL FORUM ON OVARIAN-CANCER, MAY 4-7, 1995, GLASGOW, UK, International journal of gynecological cancer, 5(6), 1995, pp. 449-458
THE PERFORMANCE OF A COMMERCIAL RADIOLIGAND BINDING ASSAY FOR THE EPIDERMAL GROWTH-FACTOR RECEPTOR IS COMPARABLE TO THE EORTC STANDARD ASSAY
Authors: OBERKANINS C GEURTSMOESPOT A ZEILLINGER R KURY F LEAKE RE BENRAAD TJ
Citation: C. Oberkanins et al., THE PERFORMANCE OF A COMMERCIAL RADIOLIGAND BINDING ASSAY FOR THE EPIDERMAL GROWTH-FACTOR RECEPTOR IS COMPARABLE TO THE EORTC STANDARD ASSAY, European journal of cancer, 31A(10), 1995, pp. 1710-1711
JUST REACTION
Authors: LEAKE RE
Citation: Re. Leake, JUST REACTION, ABA journal, 80, 1994, pp. 14-15
LEADING WHERE
Authors: LEAKE RE
Citation: Re. Leake, LEADING WHERE, ABA journal, 80, 1994, pp. 15-15
STEROID-GROWTH FACTOR INTERACTION IN HUMAN PROSTATE-CANCER .1. SHORT-TERM EFFECTS OF TRANSFORMING GROWTH-FACTORS ON GROWTH OF HUMAN PROSTATE-CANCER CELLS
Authors: CARRUBA G LEAKE RE RINALDI F CHALMERS D COMITO L SORCI C PAVONEMACALUSO M CASTAGNETTA LAM
Citation: G. Carruba et al., STEROID-GROWTH FACTOR INTERACTION IN HUMAN PROSTATE-CANCER .1. SHORT-TERM EFFECTS OF TRANSFORMING GROWTH-FACTORS ON GROWTH OF HUMAN PROSTATE-CANCER CELLS, Steroids, 59(7), 1994, pp. 412-420
IMMUNOREACTIVITY OF ANTIBODIES TO EPIDERMAL GROWTH-FACTOR, TRANSFORMING GROWTH FACTOR-ALPHA AND FACTOR-BETA, AND EPIDERMAL GROWTH-FACTOR RECEPTOR IN THE PREMENOPAUSAL OVARY
Authors: SCURRY JP HAMAND KA ASTLEY SB LEAKE RE WELLS M
Citation: Jp. Scurry et al., IMMUNOREACTIVITY OF ANTIBODIES TO EPIDERMAL GROWTH-FACTOR, TRANSFORMING GROWTH FACTOR-ALPHA AND FACTOR-BETA, AND EPIDERMAL GROWTH-FACTOR RECEPTOR IN THE PREMENOPAUSAL OVARY, Pathology, 26(2), 1994, pp. 130-133
CYCLIC SEQUENTIAL ENDOCRINE THERAPY FOR ADVANCED BREAST-CANCER USING A COMBINATION OF TAMOXIFEN AND MEGESTROL-ACETATE
Authors: CRAWFORD DJ GEORGE WD SMITH DC STEWART M PAUL J LEAKE RE
Citation: Dj. Crawford et al., CYCLIC SEQUENTIAL ENDOCRINE THERAPY FOR ADVANCED BREAST-CANCER USING A COMBINATION OF TAMOXIFEN AND MEGESTROL-ACETATE, Oncology, 51, 1994, pp. 13-18
ADJUVANT OVARIAN ABLATION VERSUS CMF CHEMOTHERAPY IN PREMENOPAUSAL WOMEN WITH PATHOLOGICAL STAGE-II BREAST-CARCINOMA - THE SCOTTISH TRIAL
Authors: BARTLETT K EREMIN O HUTCHEON A DEWAR J PREECE P CHETTY U FORREST APM HAWKINS RA LEONARD RCF PRESCOTT RJ RODGER A GEORGE WD HABESHAW T HARNETT A KAYE S LEAKE RE MCARDLE CS MCCALLUM HMM SMITH DC WALSH PV EVERINGTON D MCDONALD CC STEWART HJ CHAUDARY MA FENTIMAN IS KING RJB RICHARDS MA RUBENS RD TONG D WINTER PJ
Citation: K. Bartlett et al., ADJUVANT OVARIAN ABLATION VERSUS CMF CHEMOTHERAPY IN PREMENOPAUSAL WOMEN WITH PATHOLOGICAL STAGE-II BREAST-CARCINOMA - THE SCOTTISH TRIAL, Lancet, 341(8856), 1993, pp. 1293-1298
Risultati: 1-13 |